Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Crowe

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Asia-Pacific Journal of Clinical Oncology|January 31, 2022
Managing patients with advanced soft tissue sarcoma: Evolving landscape from an Australian perspectiveSusie Bae, Alan Brnabic, Philip Crowe, et al.
Translational Vision Science & Technology|January 29, 2021
A Cross-Sectional Study of Sub-Basal Corneal Nerve Reduction Following Neurotoxic ChemotherapyJeremy Chung Bo Chiang, David Goldstein, Terry Trinh, et al.
Cancer Medicine|May 23, 2022
Mesenchymal chondrosarcoma: An Australian multi-centre cohort studyMadeleine C Strach, Peter S Grimison, Angela Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2010
Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesisMoriko Ito, Louise Barys, Terence O'Reilly, et al.
NPJ Precision Oncology|February 13, 2021
Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumorSumanth Nagabushan, Loretta M S Lau, Paulette Barahona, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse OutcomesNicola S Meagher, Kylie L Gorringe, Matthew Wakefield, et al.
Research Square|November 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinomaDale Garsed, Tibor Zwimpfer, Sian Fereday, et al.
Nature Communications|April 1, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinomaTibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Cancer|December 27, 2022
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium studyEun-Young Kang, Ashley Weir, Nicola S Meagher, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Beyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i>-deficient tubo-ovarian high-grade serous carcinomaTibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Asia-Pacific Journal of Clinical Oncology|January 31, 2022
Managing patients with advanced soft tissue sarcoma: Evolving landscape from an Australian perspectiveSusie Bae, Alan Brnabic, Philip Crowe, et al.
Translational Vision Science & Technology|January 29, 2021
A Cross-Sectional Study of Sub-Basal Corneal Nerve Reduction Following Neurotoxic ChemotherapyJeremy Chung Bo Chiang, David Goldstein, Terry Trinh, et al.
Cancer Medicine|May 23, 2022
Mesenchymal chondrosarcoma: An Australian multi-centre cohort studyMadeleine C Strach, Peter S Grimison, Angela Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2010
Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesisMoriko Ito, Louise Barys, Terence O'Reilly, et al.
NPJ Precision Oncology|February 13, 2021
Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumorSumanth Nagabushan, Loretta M S Lau, Paulette Barahona, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse OutcomesNicola S Meagher, Kylie L Gorringe, Matthew Wakefield, et al.
Research Square|November 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinomaDale Garsed, Tibor Zwimpfer, Sian Fereday, et al.
Nature Communications|April 1, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinomaTibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Cancer|December 27, 2022
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium studyEun-Young Kang, Ashley Weir, Nicola S Meagher, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Beyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i>-deficient tubo-ovarian high-grade serous carcinomaTibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Pageof 4